Epidemiology and Prevention of Infection and Related Diseases
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 75N91024R00005
- Agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Costa Rica
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health National Cancer Institute seeks epidemiology and prevention services to build evidence for HPV vaccine protection in adolescents and adults with the goal of controlling cervical cancer globally in the next decade. Offerors must provide research, technical assistance, and consultation on topics such as infectious disease transmission dynamics, vaccine development and testing, disease surveillance programs, and health communication interventions. Proposals are due January 20, 2023 through beta.SAM.gov and will be evaluated based on technical qualifications and understanding of requirements.
No set-aside will be used. Services fall under NAICS 541715 and PSC code D302 with work performed in Costa Rica. Multiple awards are expected for a one year base period and four one-year options not exceeding a total of $50 million. The contractor will enroll and follow participants in new infection-related disease studies, provide screening, diagnosis and treatment procedures, and maintain data and biospecimen collection through 2028.
Notice text
2 versions
Update #2 · Latest ·
**Amendment 1 Response to Questions Added**
The objective is to build a comprehensive body of evidence evaluating HPV vaccine protection for adolescents and adults with the ultimate goal to make huge advances towards controlling cervical cancer globally in the next decade. Secondary goals are to study the epidemiology and prevention of infections and related diseases of public health importance using the infrastructure and methodology developed within the HPV vaccination framework.
The Contractor shall be the liaison, prepare study materials and forms, train staff, follow-up with study participants, conduct screenings, provide a diagnosis and treatment procedures for cervical disease, enter and maintain data, collect biospecimens and data, store specimens, ship biological specimens, conduct sample testing, and provide study monitoring. In addition, the Contractor shall enroll and follow, if required, participants in new studies of HPV infection and related diseases of importance to public health.
Update #1 ·
The objective is to build a comprehensive body of evidence evaluating HPV vaccine protection for adolescents and adults with the ultimate goal to make huge advances towards controlling cervical cancer globally in the next decade. Secondary goals are to study the epidemiology and prevention of infections and related diseases of public health importance using the infrastructure and methodology developed within the HPV vaccination framework.
The Contractor shall be the liaison, prepare study materials and forms, train staff, follow-up with study participants, conduct screenings, provide a diagnosis and treatment procedures for cervical disease, enter and maintain data, collect biospecimens and data, store specimens, ship biological specimens, conduct sample testing, and provide study monitoring. In addition, the Contractor shall enroll and follow, if required, participants in new studies of HPV infection and related diseases of importance to public health.
Files
| File | Type | Posted |
|---|---|---|
| 75N91024R00005 Amend P00001 kp.pdf | ||
| 75N91024R00005 final 122023.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Epidemiology and Prevention of Infection and Related Diseases | Award Notice | |
| This notice | Solicitation | |
| Epidemiology and Prevention of Infection and Related Diseases | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Pre-Clinical Models of Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside | |
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity